Work

Abstract PS3-11-30: Neoadjuvant pyrotinib, trastuzumab, dalpiciclib, and exemestane in triple-positive breast cancer: a multicenter phase II trial

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps3-11-30

Authors: P. Fu, L. Chen, M. Yao, C. Du, Y. Li, J. Zhou, S. Chen, S. Cai, Q. Feng

Institutions: First Affiliated Hospital Zhejiang University, Zhejiang University, Women's Hospital, School of Medicine, Zhejiang University, Lishui Central Hospital

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130691131

Cites:

Cited by:

Related to: